Compugen (CGEN) Total Liabilities (2009 - 2026)
Compugen recorded quarterly Total Liabilities of $50.5 million in Q1 2026, down 6.19% quarter-over-quarter from $53.8 million in Q4 2025.
Compugen's Total Liabilities history runs 12 years deep, the most recent figure standing at $50.5 million for Q1 2026.
- In Q1 2026, Total Liabilities changed N/A year-over-year to $50.5 million; the TTM figure through Mar 2026 stood at $50.5 million (changed N/A YoY), while the FY2025 annual figure was $53.8 million, down 10.39% from the prior year.
- Total Liabilities came in at $50.5 million for Q1 2026 at Compugen, down from $53.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $60.1 million in Q4 2024 to a low of $16.5 million in Q4 2022.
- A 5-year average of $47.3 million and a median of $53.8 million in 2025 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities tumbled 35.23% in 2022 and soared 238.11% in 2023, its largest moves.
- Compugen's Total Liabilities stood at $16.5 million in 2022, then jumped by 238.11% to $55.8 million in 2023, then increased by 7.72% to $60.1 million in 2024, then declined by 10.39% to $53.8 million in 2025, then slipped by 6.19% to $50.5 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $50.5 million, $53.8 million, and $60.1 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 50.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.51 Mn |
| Dec 31, 2025 | 53.84 Mn |
| Dec 31, 2024 | 60.08 Mn |
| Dec 31, 2023 | 55.78 Mn |
| Dec 31, 2022 | 16.50 Mn |
| Dec 31, 2021 | 25.47 Mn |
| Dec 31, 2020 | 18.53 Mn |
| Dec 31, 2019 | 15.44 Mn |
| Dec 31, 2018 | 15.94 Mn |
| Dec 31, 2013 | 24.82 Mn |
| Dec 31, 2012 | 11.24 Mn |
| Dec 31, 2011 | 9.50 Mn |
| Dec 31, 2010 | 8.17 Mn |
| Dec 31, 2009 | 2.79 Mn |